Chapter. Guaiac Screening CHAPTER 4: GUAIAC TESTING SCREENING FOR OCCULT BLOOD. Page 1 of 5 Guaiac 3-5-02.doc 6/24/2005



Similar documents
Contents. Approved by: Kent Lewandrowski, M.D. 6/1/2005 Written/Updated by: Gino Pagnani Date: 4/3/09

OneStep Fecal Occult Blood RapiDip InstaTest. Cat #

FECAL & GASTRIC OCCULT BLOOD TEST

PCD Europe, Jan Interpretation of Hemoccult

Chapter 14 Urinalysis, Body Fluids and Other Specimens. Objectives:

URINE DIPSTICK Multistix 10SG

CRMC Laboratory Draw Station is located in the Out Patient Services area. We are available 6AM to 6PM daily.

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

COLORECTAL CANCER SCREENING

Gastrointestinal Bleeding

Florida Nursing Assistant Academy #2926 COURSE SYLLABUS

Problems of the Digestive System

Vaginal ph Test (ph Hydrion TM Paper )

The Forzani MacPhail Colon Cancer Screening Centre Frequently Asked Questions. What is the Forzani MacPhail Colon Cancer Screening Centre?

Crime Scene Unit Presumptive Testing Procedures. Evidence Collection Division

By Anne C. Travis, M.D., M.Sc. and John R. Saltzman, M.D., FACG Brigham and Women's Hospital Harvard Medical School Boston, MA

SAMPLE PROCEDURE , 09/11

Medication Guide. Serious loss of body fluid (dehydration) and changes in blood salts (electrolytes) in your blood.

Urinalysis Compliance Tools. POCC Webinar January 19, 2011 Dr. Susan Selgren

Bowel cancer: should I be screened?

Abnormal Uterine Bleeding FAQ Sheet

Epi procolon The Blood Test for Colorectal Cancer Screening

Participate in Cancer Screening

Cancer Expert Working Group on Cancer Prevention and Screening. Prevention and Screening for Colorectal Cancer

Oxivir Tb and Accelerated Hydrogen Peroxide (AHP) Frequently Asked Questions

Cidex OPA Solution Training Checklist and Competency for Semi-Critical Medical Devices

TEST UPDATE: Ova and Parasites Effective: September 2008

General. What is a laboratory test? What is a waived test?

MEDICAL ASSISTANT PROGRAM (Diploma)

I can t empty my rectum without pressing my fingers in or near my vagina

Mouse IgM ELISA. Cat. No. KT-407 K-ASSAY. For the quantitative determination of IgM in mouse biological samples. For Research Use Only. 1 Rev.

ILLINOIS DEPARTMENT OF CENTRAL MANAGEMENT SERVICES CLASS SPECIFICATION CLINICAL LABORATORY TECHNICIAN SERIES

X-ray (Radiography), Lower GI Tract

Brachytherapy: Low Dose Rate (LDR) Radiation Interstitial Implant

LABORATORY PROCEDURE MANUAL

Planning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation

Ontario Health Insurance Plan (OHIP) Billing Codes Information and Procedures for Claiming the Cumulative Preventative Care Bonus

Colon Cancer. What Is Colon Cancer? What Are the Screening Methods?

INTRODUCTION TO CLINICAL PRACTICE AND CLINICAL SKILLS 2nd Year MEDICAL YEAR 2009/2010

SAFE HEALTHY CHILDREN A Health and Safety Manual for Childcare Providers

Quality Requirements of a Point of Care Testing Service

Humulin (HU-mu-lin) R

There are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.

Laparoscopic Surgery of the Colon and Rectum (Large Intestine) A Simple Guide to Help Answer Your Questions

IgM ELISA. For the quantitative determination of IgM in human serum and plasma. For Research Use Only. Not For Use In Diagnostic Procedures.

SCREENING FOR THE BIG THREE CANCERS: BREAST, CERVICAL and COLORECTAL. See your doctor for screening advice

Textbook: Chapter 12 pages , Chapter 13 pages

PRINTED: 10/12/2012 FORM APPROVED CENTERS FOR MEDICARE & MEDICAID SERVICES OMB NO (X2) MULTIPLE CONSTRUCTION A.

Colorectal Cancer Care A Cancer Care Map for Patients

OBJECTIVES: Visitors learn what an antioxidant is and how it behaves. They also learn how to test for the presence of vitamin C..

Aetna Life Insurance Company

Guide on the Segregation, Packaging, Labelling and Storage of Laboratory Chemical Wastes for Schools

Mechanical Systems Competency 1.20

MEDICAL ASSISTANT PROGRAM (Associate in Applied Science, AAS)

Please read the instructions 6 days before your colonoscopy.

CERVICAL CANCER What every woman should know What is a cervix?

CHOC CHILDREN SUROLOGY CENTER. Constipation

Flexible Sigmoidoscopy

Vitamin C Content of Foods

PROCEDURE COVERSHEET. Document Section: CHEMISTRY Author: JOANNE WONG Date Authored: JAN In Use Date: 2/1/2011 Discontinued Date:

Information for Men Receiving Radiation and Hormone Treatments for Prostate Cancer

Medical Assisting I. Perform general office procedures to accreditation and certification standards recognized by the American Medical Association

After Bladder Surgery (TUR-TransUrethral Resection) Discharge Information

Urinalysis and Body Fluids CRg. Chemical Exam of Urine - bilirubin. Chemical Exam of Urine - bilirubin. Unit 3. Chemical Examination of Urine

Colonoscopy or Upper GI Endoscopy

ANALYSIS OF VITAMIN C

Date: July 20, 2011 Supersedes: PS E (4/28/2010) Subject: Drug Testing of Inmates

Vitamin C Content of Fruit Juice

PREMIER PLASTIC SURGERY CENTER OF NEW JERSEY 310 MADISON AVENUE, SUITE 100, MORRISTOWN, NJ PHONE: FAX:

Laparoscopic Colectomy. What do I need to know about my laparoscopic colorectal surgery?

How To Prepare For A Colonoscopy

STEP-BY-STEP INSTRUCTIONS FOR INVESTIGATIONAL USE. Rapid HCV Antibody Test FOR ORAQUICK RAPID HCV ANTIBODY TEST

Colonoscopy Data Collection Form

Anti-Zona Pellucida Antibody Latex Agglutination Test

Maintaining Proper Bowel Elimination

BuyNuezdelaIndia.com

XV.Quality Assurance in the Blood Bank

MRP-No. DE/H/0279/001/P/002 Dr. Scheffler Vitamin C, 1000mg, effervescent tablets

Managing Acute Side Effects of Prostate Radiation Therapy

POINCIANA INTERNAL MEDICINE PA. Patient Name: Social Security Number: Date of Birth: / / Sex: M/F (Circle One) Married/Single/Divorced/Widow Address:

Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group

Caring for Your Colon. By: Saeed Ahmed, MD, Gastroenterology

Frequently Asked Questions: Ai-Detox

Determination of Specific Nutrients in Various Foods. Abstract. Humans need to consume food compounds such as carbohydrates, proteins, fats,

2.3. The management in each HCF shall be responsible for ensuring good waste management practices in their premises.

COMMUNITY REPORT March 2013 WJMC.ORG

CHAPTER V: DISPOSAL OF WASTES CONTAMINATED WITH INFECTIOUS AGENTS

Biohazardous Waste Management Plan

Preventive Care Recommendations THE BASIC FACTS

Borland-Groover Clinic PATIENT GENERATED MEDICAL HISTORY Name: DOB: Primary Care Physician: Pharmacy: Pharmacy Phone #:

Nu G Medical Waste System Technology (Pyrolysis / Thermal Decomposition)

MANAGING ANEMIA. When You Have Kidney Disease or Kidney Failure.

Revised EHS Biosafety. 1 Select appropriate containers/bags for autoclaving.

THINGS TO BE AWARE OF ABOUT PROSTATE AND LUNG CANCER. Lawrence Lackey Jr., M.D. Internal Medicine 6001 W. Outer Dr. Ste 114

CYTOTOXIC PRECAUTIONS A GUIDE FOR PATIENTS & FAMILIES

Kate O Hanlan, M. D. F. A. C. O. G., F. A. C. S.

Unaccredited Point-of-Care Laboratory Testing Guideline for Physicians

MICHAEL PIGNONE, MD, MPH

SOUTH DEARBORN COMMUNITY SCHOOL CORPORATION (SDCSC) EXTRACURRICULAR ACTIVITIES DRUG TESTING PROGRAM

Transcription:

Chapter 4 Guaiac Screening CHAPTER 4: GUAIAC TESTING SCREENING FOR OCCULT BLOOD Page 1 of 5 Guaiac 3-5-02.doc 6/24/2005

Procedure: Guaiac Testing Screening for Fecal Occult Blood POLICY: The stool occult blood slide specimen test is collected by the patient after he or she has been instructed by an RN, LPN, or medical assistant in proper diet preparation and proper test application procedure. A physician may collect a specimen at his/her diagnostic discretion upon exam. Stool occult blood slide tests may be developed and interpreted by a physician, RN, LPN, or medical assistant/medical technician certified in testing procedure. PURPOSE: To detect the presence of fecal occult blood. REAGENTS AND MATERIALS SUPPLIED: Stool occult blood slides, HEMOCULT Wooden applicators Stool Occult Blood Diet Preparation Information Sheet (sample sheet follows this procedure) with envelopes addressed to provider. PRINCIPLE: The presence of blood in the stool is determined qualitatively in the hemocult test. The heme portion of hemoglobin reacts with a special guaiac impregnated paper, oxidizing the guaiac when hydrogen peroxide (the active ingredient in the developer) is added, which then produces a blue color. CLINICAL REASONS FOR TEST: The test is recommended for use as a diagnostic aid during routine examinations to detect fecal occult blood. The test is also useful in monitoring bleeding in patients with iron deficiency anemia or recuperating from surgery, peptic ulcer, ulcerative colitis and screening programs for colorectal cancer when a special diagnostic diet is used. A positive test is not specific for any disease. SAMPLE COLLECTION AND STORAGE: Patient Preparation: Whenever possible, the patient should be on the Special Diagnostic Diet starting at least 48 hours prior and continuing through the collection period. Give the patient stool occult blood diet preparation educational materials as supplied by manufacturer. Review sheet with patient and reinforce the importance of adhering to the diet to ensure proper test result. Specimen: Preferred Stool specimen should be collected from the patient who has been on a Special Diagnostic Diet 48 hours prior to collection. Three consecutive bowel specimens should be collected on Hemoccult Slides. Acceptable Specimens: Three consecutive bowel movements collected in separate containers One random collection without Special Diet restrictions. Acceptable collection containers are plastic containers of approximately 100cc (urine type) or collection by the patient on Hemoccult slides. Dried slides containing specimen are stable up to 14 days stored at 15-30 C. Page 2 of 5 Guaiac 3-5-02.doc 6/24/2005

Unacceptable Specimens: Specimens should not be collected if hematuria or obvious rectal bleeding is present, such as might occur with hemorrhoids. Pre-menopausal women must be instructed to avoid collecting feces during or in the first three days after a menstrual cycle. KIT STORAGE AND STABILITY Hemoccult slides should be stored at 15-30 C (59 86 F). in the original packaging. Do not refrigerate or freeze. Protect from heat and light. Do not store near volatile chemicals (iodine, bromine, chloride or ammonia). Hemocult Developer should be stored at 15-30 C (59 86 F). Protect from heat. Keep bottle tightly capped when not in use. The Hemocult kit should be stored at room temperature, 15-30 C (59 86 F), out of direct sunlight. Kit contents are stable until the expiration date printed on the outer box. Do not freeze. QUALITY CONTROL: Control Materials: When using the Hemoccult slides, there is a performance monitor feature at the bottom of the slide for quality control purposes. This is an internal calibrator which must perform acceptably or the patient test results must be rejected. Frequency Performed The Performance Monitor feature must be checked with each slide. Tolerance Limits & Corrective Action The positive control must show a blue color when tested along with patients and negative control must be colorless. Record Quality Control results along with patient results in the Log Book. PROCEDURE: Specimen collection procedure: 1. Give patient stool occult blood diet preparation educational sheet as supplied by the manufacturer. Review sheet with patient and reinforce importance of adhering to diet to ensure proper test results. 2. Explain stool occult blood procedure as follows: a. Fill in the information on the front of the card. b. Collect a small stool sample on one end of the applicator. c. Apply a thin smear inside box A. d. Reuse applicator to obtain second sample from different part of stool, apply thin smear inside box B. Close cover. 1. 2. 3. 4. e. Repeat procedure once each day for three days. Caution patient not to collect specimen during menses or while suffering from hemorrhoids. Inform patient to protect slides from heat, sunlight, and fluorescent light. Instruct patient to return slides immediately in preaddressed envelope. Inform patient that follow-up care will be dependent upon test results. He or she will be notified by the provider, if further tests are indicated. HEMOCCULT SLIDE Developing Procedure: Slides are submitted to the POCT location from patients who have been instructed by their physicians or other trained medical personnel on the proper collection of specimens. 1. Fresh specimens must be allowed to dry for 5 minutes before testing. Wet samples can give false results. 2. Open flap in back of the slide. 3. Apply 2 drops of Hemoccult developer to each smear. Page 3 of 5 Guaiac 3-5-02.doc 6/24/2005

4. Read results visually within 60 seconds. Any trace of blue color on or at the edge of stool smear is considered positive for occult blood. Lack of blue color development indicates the absence of blood. 5. After patient results are noted, apply one drop of developer between the positive and negative monitor areas. 6. Read Internal QC results within 10 seconds. If the slide and developer are functional, a blue color will appear in the positive monitor area, while no blue color will appear in the negative area. INTERPRETATION OF RESULTS: Any trace of blue color developed on or at the edge of a smear in which external quality control is valid, is considered positive for the presence of occult blood. The lack of a blood color on a reagent strip in which external quality control is valid, is considered negative for the presence of occult blood. DOCUMENTATION OF RESULTS Patient results are reported as either negative or positive and are recorded on the Testing Log and in the patient s chart. Document that the patient has received instructions regarding follow up care. LIMITATIONS AND INTERFERING SUBSTANCES: Red meat may cause false positive results and should be eliminated from the diet 48 hours prior to and during the sampling phase. Fruits and vegetables high in peroxidase such as turnips, broccoli, horseradish, parsnip, cauliflower, and cantaloupe may cause false positive results. High doses of ascorbic acid (Vitamin C, 250 mg/day or more) may cause false negative results. Oral medications such as aspirin or other non-steroid anti-inflammatory drugs should be avoided for 7 days prior to and during the test period. Heavy alcohol consumption may cause irritation or bleeding of the GI tract and should be eliminated from the diet 48 hours prior to and during the sampling procedure. Contamination with menstrual blood or active bleeding due to hemorrhoids or polyps will give a false positive test. Many toilet sanitizers generate chlorine and are reported to cause false positive reactions if the test areas are contaminated on the Hemoccult Slide. Notes: Testing for occult blood is useful as a screening mechanism for lesions of the lower GI tract. Malignant tissues such as adenocarcinomas, as well as other malignant lesions of the bowel are more fragile than healthy tissues; their presence results in abnormal loss of blood into the lumen of the gut. Frequently, the detection of blood in feces is the first indication of an abnormal gastrointestinal tract pathology. In addition to malignancy, ulcers polyps, ulcerative colitis, regional enteritis, and diverticulitis may result in blood loss into the gut and yield positive results when testing for occult blood. If sent through the mail, collected specimen slides must be placed in special mailing pouches. WARNINGS AND PRECAUTIONS: Do not use the kit contents beyond the expiration date printed on the outside of the box. Use appropriate precautions in the collection, handling, storage and disposal of patient samples and used kit contents. 2 Discard used material in a proper biohazard containers. Page 4 of 5 Guaiac 3-5-02.doc 6/24/2005

ASSISTANCE: If you require assistance, please contact your POCT site supervisor, the POCT clinical coordinator, or the Department of Pathology - UDL central administrative office. If necessary, they will contact the manufacturer s technical support hotline. Written by: Evan Cadoff, M.D. Approved by: Evan Cadoff, M.D. Date: 03/05/02 Date: 03/05/02 Reviewed by: Date: 06/05/05. Reviewed by: Reviewed by: Date: Date: Page 5 of 5 Guaiac 3-5-02.doc 6/24/2005